The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Interleukin-6 (IL-6) Trans Signaling Drives a STAT3-dependent Pathway That Leads to Hyperactive Transforming Growth Factor-β (TGF-β) Signaling Promoting SMAD3 Activation and Fibrosis via Gremlin Protein
Open accessAbstract
Fibrosis is a common and intractable condition associated with various pathologies. It is characterized by accumulation of an excessive amount of extracellular matrix molecules that primarily include collagen type I. IL-6 is a profibrotic cytokine that is elevated in the prototypic fibrotic autoimmune condition systemic sclerosis and is known to induce collagen I expression, but the mechanism(s) behind this induction are currently unknown. Using healthy dermal fibroblasts in vitro, we analyzed the signaling pathways that underscore the IL-6-mediated induction of collagen. We show that IL-6 trans signaling is important and that the effect is dependent on STAT3; however, the effect is indirect and mediated through enhanced TGF-β signaling and the classic downstream cellular mediator Smad3. This is due to induction of the bone morphogenetic protein (BMP) antagonist Gremlin-1, and we show that Gremlin-1 is profibrotic and is mediated through canonical TGF-β signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
HEINRICH, P. C., BEHRMANN, I., HAAN, S., HERMANNS, H. M., MÜLLER-NEWEN, G., & SCHAPER, F. (2003) · Biochemical Journal · doi:10.1042/bj20030407 · Cited by 3,272 · cited 2×
“Once signaling is initiated, receptor-associated Janus kinases (JAKs) are activated, and signal transducers and activators of transcription (STATs) transcription factors are phosphorylated and translocate to the cell nucleus to coordinate gene expression by binding to STAT-responsive gene elements (12, 13).”
BackgroundZeisberg, M., Hanai, J.-I., Sugimoto, H., Mammoto, T., Charytan, D., Strutz, F., & Kalluri, R. (2003) · Nature Medicine · doi:10.1038/nm888 · Cited by 1,346
The soluble interleukin 6 receptor: mechanisms of production and implications in disease
JONES, S. A., HORIUCHI, S., TOPLEY, N., YAMAMOTO, N., & FULLER, G. M. (2001) · The FASEB Journal · doi:10.1096/fj.99-1003rev · Cited by 623
Pennica, D., Shaw, K. J., Swanson, T. A., Moore, M. W., Shelton, D. L., Zioncheck, K. A., Rosenthal, A., Taga, T., Paoni, N. F., & Wood, W. I. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.18.10915 · Cited by 429
Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities
Bhattacharyya, S., Wei, J., & Varga, J. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.149 · Cited by 381
DeChiara, T. M., Vejsada, R., Poueymirou, W. T., Acheson, A., Suri, C., Conover, J. C., Friedman, B., McClain, J., Pan, L., Stahl, N., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90172-8 · Cited by 379
Needleman, B. W., Wigley, F. M., & Stair, R. W. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350111 · Cited by 302
Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling
Frank, D. A., Mahajan, S., & Ritz, J. (1999) · Nature Medicine · doi:10.1038/7445 · Cited by 287
Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-β1 production
Ogata, H., Chinen, T., Yoshida, T., Kinjyo, I., Takaesu, G., Shiraishi, H., Iida, M., Kobayashi, T., & Yoshimura, A. (2006) · Oncogene · doi:10.1038/sj.onc.1209281 · Cited by 246
Effects of TGF-β2, BMP-4, and Gremlin in the Trabecular Meshwork: Implications for Glaucoma
Wordinger, R. J., Fleenor, D. L., Hellberg, P. E., Pang, I.-H., Tovar, T. O., Zode, G. S., Fuller, J. A., & Clark, A. F. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.06-0296 · Cited by 225
Role of Interleukin-6 in Bleomycin-Induced Lung Inflammatory Changes in Mice
Saito, F., Tasaka, S., Inoue, K.-I., Miyamoto, K., Nakano, Y., Ogawa, Y., Yamada, W., Shiraishi, Y., Hasegawa, N., Fujishima, S., et al. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0299oc · Cited by 221
Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis
Khan, K., Xu, S., Nihtyanova, S., Derrett-Smith, E., Abraham, D., Denton, C. P., & Ong, V. H. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200955 · Cited by 219
T cells in systemic sclerosis: a reappraisal
O'Reilly, S., Hugle, T., & van Laar, J. M. (2012) · Rheumatology · doi:10.1093/rheumatology/kes090 · Cited by 218
Self-citationGremlin is a novel agonist of the major proangiogenic receptor VEGFR2
Mitola, S., Ravelli, C., Moroni, E., Salvi, V., Leali, D., Ballmer-Hofer, K., Zammataro, L., & Presta, M. (2010) · Blood · doi:10.1182/blood-2010-06-291930 · Cited by 202
Bone Morphogenetic Protein-4 Inhibitor Gremlin Is Overexpressed in Idiopathic Pulmonary Fibrosis
Koli, K., Myllärniemi, M., Vuorinen, K., Salmenkivi, K., Ryynänen, M. J., Kinnula, V. L., & Keski-Oja, J. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.051263 · Cited by 178
Functional Implications of the IL-6 Signaling Pathway in Keloid Pathogenesis
Ghazizadeh, M., Tosa, M., Shimizu, H., Hyakusoku, H., & Kawanami, O. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700564 · Cited by 170
Kräling, B. M., Maul, G. G., & Jimenez, S. A. (1995) · Pathobiology · doi:10.1159/000163933 · Cited by 166
Dees, C., Tomčík, M., Palumbo‐Zerr, K., Distler, A., Beyer, C., Lang, V. R., Horn, A., Zerr, P., Zwerina, J., Gelse, K., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34500 · Cited by 157
O'Donoghue, R. J. J., Knight, D. A., Richards, C. D., Prêle, C. M., Lau, H. L., Jarnicki, A. G., Jones, J., Bozinovski, S., Vlahos, R., Thiem, S., et al. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100604 · Cited by 152
Fuchshofer, R., Yu, A. H. L., Welge-Lu¨ssen, U., & Tamm, E. R. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0226 · Cited by 148
Matsushita, T., Hasegawa, M., Hamaguchi, Y., Takehara, K., & Sato, S. (2006) · PubMed · Cited by 140
IHG-2, a Mesangial Cell Gene Induced by High Glucose, Is Human gremlin
McMahon, R., Murphy, M., Clarkson, M., Taal, M. W., Mackenzie, H. S., Godson, C., Martin, F., & Brady, H. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.9901 · Cited by 137
Lim, C. P., Phan, T.-T., Lim, I. J., & Cao, X. (2006) · Oncogene · doi:10.1038/sj.onc.1209531 · Cited by 136
Ray, S., Ju, X., Sun, H., Finnerty, C. C., Herndon, D. N., & Brasier, A. R. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.499 · Cited by 124
Ihn, H., Sato, S., Fujimoto, M., Kikuchi, K., & Takehara, K. (1995) · Archives of Dermatological Research · doi:10.1007/bf01262331 · Cited by 116
Transcriptional Profiling Reveals Novel Markers of Liver Fibrogenesis
BOERS, W., Aarrass, S., Linthorst, C., Pinzani, M., Elferink, R. P. J. O., & Bosma, P. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600711200 · Cited by 115
Interleukin‐6: a new therapeutic target in systemic sclerosis?
O’Reilly, S., Cant, R., Ciechomska, M., & van Laar, J. M. (2013) · Clinical & Translational Immunology · doi:10.1038/cti.2013.2 · Cited by 112
Self-citationGremlin Plays a Key Role in the Pathogenesis of Pulmonary Hypertension
Cahill, E., Costello, C. M., Rowan, S. C., Harkin, S., Howell, K., Leonard, M. O., Southwood, M. R., Cummins, E. P., Fitzpatrick, S. F., Taylor, C. T., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.038125 · Cited by 110
Interleukin-6, its role in fibrosing conditions
O’Reilly, S., Ciechomska, M., Cant, R., Hügle, T., & van Laar, J. M. (2012) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2012.04.003 · Cited by 96
Self-citationAoki, H., Ohnishi, H., Hama, K., Shinozaki, S., Kita, H., Yamamoto, H., Osawa, H., Satō, K., Tamada, K., & Sugano, K. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20906 · Cited by 85
Hügle, T., O’Reilly, S., Simpson, R., Kraaij, M. D., Bigley, V., Collin, M. P., Krippner‐Heidenreich, A., & van Laar, J. M. (2012) · Arthritis & Rheumatism · doi:10.1002/art.37738 · Cited by 76
Self-citationIL-6 Blockade Attenuates the Development of Murine Sclerodermatous Chronic Graft-Versus-Host Disease
Huu, D. L., Matsushita, T., Jin, G., Hamaguchi, Y., Hasegawa, M., Takehara, K., & Fujimoto, M. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.226 · Cited by 67
Šošić‐Jurjević, B., Filipović, B. R., Milošević, V., Nestorović, N. M., Manojlović‐Stojanoski, M., Brkić, B., & Sekulić, M. (2005) · Hormone Research in Paediatrics · doi:10.1159/000083139 · Cited by 46
SOCS3 regulates graft-versus-host disease
Hill, G. R., Kuns, R. D., Raffelt, N. C., Don, A. L. J., Olver, S. D., Markey, K. A., Wilson, Y. A., Tocker, J. E., Alexander, W. S., Clouston, A. D., et al. (2010) · Blood · doi:10.1182/blood-2009-12-259598 · Cited by 40
Mueller, K. A. L., Tavlaki, E., Schneider, M., Jorbenadze, R., Geisler, T., Kandolf, R., Gawaz, M., Zuern, C. S., & Mueller, I. I. (2013) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2013.09.001 · Cited by 40
Cited by
Yang (2021) · doi:10.1038/s41598-020-79139-8 · Cited by 5,035
Mack, M. (2018) · Matrix Biology · doi:10.1016/j.matbio.2017.11.010 · Cited by 514
The role of IL-6 in host defence against infections: immunobiology and clinical implications
Rose-John, S., Winthrop, K., & Calabrese, L. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.83 · Cited by 424
Pathogenesis of Systemic Sclerosis
Pattanaik, D., Brown, M., Postlethwaite, B. C., & Postlethwaite, A. E. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00272 · Cited by 405
Autophagy as a molecular target for cancer treatment
Kocaturk, N. M., Akkoc, Y., Kig, C., Bayraktar, O., Gozuacik, D., & Kutlu, O. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.04.011 · Cited by 387
Metadata
- Authors
- O'Reilly, S., Ciechomska, M., Cant, R., & van Laar, J. M.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2014-04
- Volume
- 289
- Issue
- 14
- Pages
- 9952-9960
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1970190279
- Cited by
- 258
- References
- 35
- FWCI
- 7.67
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.